Green Alpha Advisors, LLC Gilead Sciences, Inc. Transaction History

Green Alpha Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$57.72 - $65.01 $1.42 Million - $1.59 Million	24,522 New	24,522 $1.52 Million
Q2 2021 Jul 22, 2021	SELL	$63.47 - $69.35 $275,332 - $300,840	-4,338 Closed	0 $0
Q1 2021 Jul 22, 2021	SELL	$60.0 - $68.46 $131,160 - $149,653	-2,186 Reduced 33.51%	4,338 $280,000
Q4 2020 Jul 22, 2021	BUY	$56.65 - $64.55 $369,584 - $421,124	6,524 New	6,524 $380,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Green Alpha Advisors, LLC with notifications on news.